Pharma / Biotech

Physiologically Based Pharmacokinetic Modelling of Glycopyrronium in Patients with Renal Impairment.



Icon for Elsevier Science Related Articles

Physiologically Based Pharmacokinetic Modelling of Glycopyrronium in Patients with Renal Impairment.

J Pharm Sci. 2020 Mar 30;:

Authors: Higashimori M, Ishikawa K, Gillen M, Zhou D

Abstract
Glycopyrronium bromide, a synthetic anticholinergic agent used to treat patients with chronic obstructive pulmonary disease (COPD), is eliminated from the body by renal excretion and therefore systemic exposure is expected to be increased in patients with decreasing renal function. Despite enrollment of patients with decreasing renal function to evaluate the impact of renal impairment on the pharmacokinetics of glycopyrronium in clinical studies, no patients with severe renal impairment were included. A physiologically based pharmacokinetic (PBPK) model was developed in patients with COPD with normal renal function and used to predict systemic exposure of glycopyrronium in patients with severe renal impairment. The model accurately predicted plasma concentration-time profiles in patients with normal renal function, and mild and moderate renal impairment; the predicted and observed AUC and Cmax in these populations were similar. Compared to patients with normal renal function, a 1.20-, 1.45-, and 1.59-fold increase AUC was predicted in patients with mild, moderate, and severe renal impairment, respectively, suggesting dose adjustment is not necessary in patients with renal impairment. In conclusion, PBPK models, verified with clinical study data from patients with normal renal function, can potentially be used to predict the pharmacokinetics and recommended dose adjustment for patients with renal impairment.

PMID: 32240691 [PubMed – as supplied by publisher]

Source link






Related posts

What is cephalexin?

Newsemia

Ofev Approved for Interstitial Lung Disease

Newsemia

Certain Psychiatric Drugs May Raise Pneumonia Risk

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy